SLG
62
-4
ABT
57
-5
SRE
66
-3
DGX
48
-3
JCI
61
-2
DFS
67
-3
STI
31
19
PWR
71
-3
HUM
48
2
SIG
47
-2
DRI
56
2
STZ
58
3
STX
52
-4
MRO
46
3
ADI
45
-5
KO
44
2
NOV
58
-2
PX
73
-6
TEL
74
3
AES
41
2
SLG
62
-4
ABT
57
-5
SRE
66
-3
DGX
48
-3
JCI
61
-2
DFS
67
-3
STI
31
19
PWR
71
-3
HUM
48
2
SIG
47
-2
DRI
56
2
STZ
58
3
STX
52
-4
MRO
46
3
ADI
45
-5
KO
44
2
NOV
58
-2
PX
73
-6
TEL
74
3
AES
41
2
Financhill
Back

Immuneering Stock Price Chart

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Sell
28

IMRX
Immuneering

Last Price:
1.93
Seasonality Move:
-29.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMRX is experiencing selling pressure, which indicates risk of future bearish movement.

Immuneering Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.88 Sell
20-day SMA: 1.99 Sell
50-day SMA: 2.14 Sell
200-day SMA: 2.4 Sell
8-day EMA: 1.86 Sell
20-day EMA: 1.97 Sell
50-day EMA: 1.97 Sell
200-day EMA: 2.76 Sell

Immuneering Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 36.65 Sell
Chaikin Money Flow: -202643 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.87 - 2.19) Sell
Bollinger Bands (100): (1.08 - 2.24) Buy

Immuneering Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Immuneering Stock

Is Immuneering Stock a Buy?

  • Immuneering share price is 1.71 while IMRX 8-day simple moving average is 1.88, which is a Sell signal.
  • The stock price of IMRX is 1.71 while Immuneering 20-day SMA is 1.99, which makes it a Sell.
  • Immuneering 50-day simple moving average is 2.14 while IMRX share price is 1.71, making it a Sell technically.
  • IMRX stock price is 1.71 and Immuneering 200-day simple moving average is 2.40, creating a Sell signal.

IMRX Technical Analysis vs Fundamental Analysis

Sell
28
Immuneering (IMRX) is a Sell

Is Immuneering a Buy or a Sell?

  • Immuneering stock is rated a Sell
    The current Immuneering [IMRX] share price is $1.71. The Score for IMRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.

Immuneering Stock Info

Market Cap:
50.71M
Price in USD:
1.71
Share Volume:
293.63K

Immuneering 52-Week Range

52-Week High:
8.89
52-Week Low:
1.00
Sell
28
Immuneering (IMRX) is a Sell

Immuneering Share Price Forecast

  • What is the Immuneering stock price today?
    The Immuneering stock price is 1.71 USD today.
  • Will IMRX stock go up or go down?
    Immuneering> share price is forecast to RISE/FALL based on technical indicators
  • Is Immuneering overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Immuneering is overvalued.

Is Immuneering Stock a Buy?

  • Immuneering share price is 1.71 while IMRX 8-day exponential moving average is 1.86, which is a Sell signal.
  • The stock price of IMRX is 1.71 while Immuneering 20-day EMA is 1.97, which makes it a Sell.
  • Immuneering 50-day exponential moving average is 1.97 while IMRX share price is 1.71, making it a Sell technically.
  • IMRX stock price is 1.71 and Immuneering 200-day simple moving average is 2.76, creating a Sell signal.

Fundamental Analysis of Immuneering

Is Immuneering a good investment?

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.20 per share.

Technical Analysis of Immuneering

Should I short Immuneering stock?

* Immuneering stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.